Overview
- 16 inspections across 16 sites are on record.
- 0 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2025-04-24.
At a glance
Inspections
16
Sites
16
Observations
0
Career since
Feb 2017
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Replimune, Inc. | 24 Apr 2025 | Biologics | On file |
| Replimune Limited | 26 Mar 2025 | Biologics | On file |
| Bavarian Nordic Berna GmbH | 18 Oct 2024 | Biologics | |
| Grand River Aseptic Manufacturing, Inc. | 19 Sep 2024 | Biologics | On file |
| EdgeOne Medical Inc. | 5 Sep 2024 | Biologics |
Sites inspected
Replimune, Inc.Woburn, United States1 insp.
Replimune LimitedOxford, United Kingdom1 insp.
Bavarian Nordic Berna GmbHThorishaus, Switzerland1 insp.
Grand River Aseptic Manufacturing, Inc.Grand Rapids, United States1 insp.
EdgeOne Medical Inc.Wheeling, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Donald B Ertel3 shared
Andrew P Byrnes3 shared
Bo Liang2 shared
Anna R Kwilas2 shared
Carl A Perez2 shared
Christine Harman2 shared
Michael B Havert2 shared
Arie Menachem2 shared
Carla A Lorenzo1 shared
Guo-Chiuan Hung1 shared
Full investigator report
Get the verbatim findings behind Wei Wang's inspection record
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site